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Background and Objective: HBHA and Mtb32C have been isolated from culture supernatants of Mycobacterium tuberculosis (M. tuberculosis) and
Mycobacterium bovis (M. bovis) and their immunogenicity in previous studies have been confirmed. In this study, capability of constructed vector
containing two mycobacterial immunodaminant antigens (Mtb32C-HBHA), in producing new chimeric protein under the in-vitro condition was examined.
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Materials and Methods: In present study Huh7.5 cells was transfected with Mtb32C-HBHA –pCDNA3.1+ recombinant vector by using the calcium
phosphate method and expression of chimeric protein was assessed by RT-PCR and Western blot methods.
Results: Recombinant vector introduce to Huh7.5 cell and generation of recombinant Mtb32C-HBHA protein was evaluated by RT-PCR and Western blot
methods. Results of RT-PCR and Western blot showed expression of 35.5 KD recombinant protein (Mtb32C-HBHA) in this cell line(Fig1,2,3).
Conclusion:
This study indicated, the constructed vector can produce two highly immunogenic antigens that fusion of them to gather makes chimeric antigen with
new traits. Other attempts are needed to evaluate specific properties of this new antigen such as molecular conformation modeling and immunologic
characteristics in future studies.
Fig.1: Gel electrophoresis of the recombinant vector
encoding mtb32C-hbha fusion gene, after purification.
Lanes 1 and 2: purified recombinant vector containing
mtb32C-hbha genes; lane3: 100bp DNA size marker
(Fermentas, Germany)
Figure 2: Identification of Mtb32C mRNA in transfected and non-
transfected Huh-7.5 cells by RT-PCR method. A 400bp fragment was
amplified by RT-PCR method in transfected cells (lane 2); no amplification
was resulted by RT-PCR on extracted RNA treated with DNase Ι (lane 3)
and on synthesized cDNA of non transfected cells (lane 4). Lanes 1 and 5:
100bp DNA size marker (Fermentas, Germany)
Fig 3: Recognition of an approximately 35.5 kDa band corresponding
to Mtb32C-HBHA fusion protein in transfected cells (Lane 1) and
non-transfected cells (Lane 2) by Western blot method
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